This is more consistent with another meta-analysis of 19 studies by Marabelli M. et al. [56], which reported that the female carriers of ATM variants have a breast cancer relative risk of 6.02 by the age of 50 years old and 32.83 by the age of 80 years old. Here, ATM is linked to breast cancer.